The role of metabolic reprogramming in kidney cancer

被引：0
|
作者：
Chen, Ziyi [1 ]
Zhang, Xiaohong [2 ,3 ,4 ]
机构：
[1] Fujian Med Univ, Clin Med Coll 1, Fuzhou, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Blood Purificat Res Ctr, Dept Nephrol, Fuzhou, Peoples R China
[3] Fujian Med Univ, Affiliated Hosp 1, Fujian Clin Res Ctr Metab Chron Kidney Dis, Fuzhou, Peoples R China
[4] Fujian Med Univ, Affiliated Hosp 1, Natl Reg Med Ctr, Dept Nephrol, Binhai Campus, Fuzhou, Peoples R China
来源：
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词：
metabolism reprogramming; renal cancer; treatment; glucose metabolism; amino acid metabolism; RENAL-CELL CARCINOMA; GROWTH; MYC; PROLIFERATION; HOMEOSTASIS; EXPRESSION; INHIBITORS; ADENOSINE; PATHWAY; BENEFIT;
D O I：
10.3389/fonc.2024.1402351
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Metabolic reprogramming is a cellular process in which cells modify their metabolic patterns to meet energy requirements, promote proliferation, and enhance resistance to external stressors. This process also introduces new functionalities to the cells. The 'Warburg effect' is a well-studied example of metabolic reprogramming observed during tumorigenesis. Recent studies have shown that kidney cells undergo various forms of metabolic reprogramming following injury. Moreover, metabolic reprogramming plays a crucial role in the progression, prognosis, and treatment of kidney cancer. This review offers a comprehensive examination of renal cancer, metabolic reprogramming, and its implications in kidney cancer. It also discusses recent advancements in the diagnosis and treatment of renal cancer.
引用
收藏
页数：9
相关论文
共 50 条
  • [1] Metabolic reprogramming and kidney cancer progression
    DeBerardinis, Ralph J.
    [J]. CANCER RESEARCH, 2023, 83 (16)
  • [2] Metabolomics and Metabolic Reprogramming in Kidney Cancer
    Weiss, Robert H.
    [J]. SEMINARS IN NEPHROLOGY, 2018, 38 (02) : 175 - 182
  • [3] Metabolic reprogramming and the role of mitochondria in polycystic kidney disease
    Podrini, Christine
    Cassina, Laura
    Boletta, Alessandra
    [J]. CELLULAR SIGNALLING, 2020, 68
  • [4] The role of metabolic reprogramming in pancreatic cancer chemoresistance
    Liu, Chang
    Li, Changfeng
    Liu, Yuanda
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 13
  • [5] The biological role of metabolic reprogramming in pancreatic cancer
    Suzuki, Tatsunori
    Otsuka, Motoyuki
    Seimiya, Takahiro
    Iwata, Takuma
    Kishikawa, Takahiro
    Koike, Kazuhiko
    [J]. MEDCOMM, 2020, 1 (03): : 302 - 310
  • [6] Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming
    Zhu, Zijing
    Hu, Jijia
    Chen, Zhaowei
    Feng, Jun
    Yang, Xueyan
    Liang, Wei
    Ding, Guohua
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 131
  • [7] The role of YAP/TAZ activity in cancer metabolic reprogramming
    Xiaodong Zhang
    Haiying Zhao
    Yan Li
    Di Xia
    Liang Yang
    Yingbo Ma
    Hangyu Li
    [J]. Molecular Cancer, 17
  • [8] The role of noncoding RNAs in metabolic reprogramming of cancer cells
    Amir Safi
    Mohammadreza Saberiyan
    Mohammad-Javad Sanaei
    Samaneh Adelian
    Fateme Davarani Asl
    Mahsa Zeinaly
    Mahdi Shamsi
    Reza Ahmadi
    [J]. Cellular & Molecular Biology Letters, 28
  • [9] Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
    Daye, Dania
    Wellen, Kathryn E.
    [J]. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2012, 23 (04) : 362 - 369
  • [10] The role of YAP/TAZ activity in cancer metabolic reprogramming
    Zhang, Xiaodong
    Zhao, Haiying
    Li, Yan
    Xia, Di
    Yang, Liang
    Ma, Yingbo
    Li, Hangyu
    [J]. MOLECULAR CANCER, 2018, 17
12345